BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30019850)

  • 1. Exploring the predictive power of the unspecific risk category of the Basel Screening Instrument for Psychosis.
    Peralta D; Studerus E; Andreou C; Beck K; Ittig S; Leanza L; Egloff L; Riecher-Rössler A
    Early Interv Psychiatry; 2019 Aug; 13(4):969-976. PubMed ID: 30019850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of individuals "not at risk of psychosis" and prognostic accuracy of the Basel Screening Instrument for Psychosis (BSIP).
    Papmeyer M; Aston J; Everts-Graber J; Heitz U; Studerus E; Borgwardt SJ; Stieglitz RD; Riecher-Rössler A
    Early Interv Psychiatry; 2018 Oct; 12(5):907-914. PubMed ID: 28429847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
    Nelson B; Yuen K; Yung AR
    Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of psychosis by stepwise multilevel assessment--the Basel FePsy (Early Recognition of Psychosis)-Project].
    Riecher-Rössler A; Aston J; Borgwardt S; Bugra H; Fuhr P; Gschwandtner U; Koutsouleris N; Pflueger M; Tamagni C; Radü EW; Rapp C; Smieskova R; Studerus E; Walter A; Zimmermann R
    Fortschr Neurol Psychiatr; 2013 May; 81(5):265-75. PubMed ID: 23695791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EPA guidance on the early detection of clinical high risk states of psychoses.
    Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
    Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity].
    Riecher-Rössler A; Aston J; Ventura J; Merlo M; Borgwardt S; Gschwandtner U; Stieglitz RD
    Fortschr Neurol Psychiatr; 2008 Apr; 76(4):207-16. PubMed ID: 18393134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Significance of Brief Limited Intermittent Psychotic Symptoms (BLIPS) in Individuals at Ultra High Risk.
    Fusar-Poli P; Cappucciati M; De Micheli A; Rutigliano G; Bonoldi I; Tognin S; Ramella-Cravaro V; Castagnini A; McGuire P
    Schizophr Bull; 2017 Jan; 43(1):48-56. PubMed ID: 28053130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early psychosis detection program in Chile: A first step for the South American challenge in psychosis research.
    Gaspar PA; Castillo RI; Maturana A; Villar MJ; Ulloa K; González G; Ibaceta O; Ortiz A; Corral S; Mayol R; De Angel V; Aburto MB; Martínez A; Corcoran CM; Silva H
    Early Interv Psychiatry; 2019 Apr; 13(2):328-334. PubMed ID: 30548415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S; Schultze-Lutter F; Salokangas RK; Heinimaa M; Linszen D; Dingemans P; Birchwood M; Patterson P; Juckel G; Heinz A; Morrison A; Lewis S; von Reventlow HG; Klosterkötter J
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.